{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T08:17:40Z","timestamp":1789805860653,"version":"4.0.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100017668","name":"Anhui Provincial Key Research and Development Plan","doi-asserted-by":"publisher","award":["Grant No. 201904a07020057"],"award-info":[{"award-number":["Grant No. 201904a07020057"]}],"id":[{"id":"10.13039\/501100017668","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Research Foundation of Anhui Medical University","award":["Grant No.2020xkj166"],"award-info":[{"award-number":["Grant No.2020xkj166"]}]},{"name":"Clinical Trial Initiative Projects of The First Affiliated Hospital of Anhui Medical University","award":["Grant No. LCYJ2021YB009"],"award-info":[{"award-number":["Grant No. LCYJ2021YB009"]}]},{"name":"Research Foundation of Anhui Institute of Translational Medicine","award":["Grant No. 2021zhyx-C32"],"award-info":[{"award-number":["Grant No. 2021zhyx-C32"]}]},{"DOI":"10.13039\/501100003995","name":"Natural Science Foundation of Anhui province","doi-asserted-by":"crossref","award":["Grant No.2008085QH365"],"award-info":[{"award-number":["Grant No.2008085QH365"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-023-02056-z","type":"journal-article","created":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T10:02:12Z","timestamp":1685613732000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Dexamethasone enhances venetoclax-induced apoptosis in acute myeloid leukemia cells"],"prefix":"10.1007","volume":"40","author":[{"given":"Haixia","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changqing","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enbo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengya","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianling","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengxin","family":"Luan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6963-287X","authenticated-orcid":false,"given":"Jian","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,1]]},"reference":[{"issue":"12","key":"2056_CR1","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJMra1406184","volume":"373","author":"H Dohner","year":"2015","unstructured":"Dohner H, Weisdorf DJ, Bloomfield CD. Acute Myeloid Leukemia. N Engl J Med. 2015;373(12):1136\u201352.","journal-title":"N Engl J Med"},{"issue":"7","key":"2056_CR2","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1182\/blood-2016-09-670224","volume":"129","author":"C Korn","year":"2017","unstructured":"Korn C, Mendez-Ferrer S. Myeloid malignancies and the microenvironment. Blood. 2017;129(7):811\u201322.","journal-title":"Blood"},{"issue":"2","key":"2056_CR3","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1182\/blood-2015-07-655860","volume":"128","author":"R Moschoi","year":"2016","unstructured":"Moschoi R, Imbert V, Nebout M, Chiche J, Mary D, Prebet T, Saland E, Castellano R, Pouyet L, Collette Y, et al. Protective mitochondrial transfer from bone marrow stromal cells to acute myeloid leukemic cells during chemotherapy. Blood. 2016;128(2):253\u201364.","journal-title":"Blood"},{"issue":"5","key":"2056_CR4","doi-asserted-by":"crossref","first-page":"7946","DOI":"10.18632\/oncotarget.13853","volume":"8","author":"M Omsland","year":"2017","unstructured":"Omsland M, Bruserud O, Gjertsen BT, Andresen V. Tunneling nanotube (TNT) formation is downregulated by cytarabine and NF-kappaB inhibition in acute myeloid leukemia (AML). Oncotarget. 2017;8(5):7946\u201363.","journal-title":"Oncotarget"},{"issue":"14","key":"2056_CR5","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1182\/blood-2017-03-772939","volume":"130","author":"CR Marlein","year":"2017","unstructured":"Marlein CR, Zaitseva L, Piddock RE, Robinson SD, Edwards DR, Shafat MS, Zhou Z, Lawes M, Bowles KM, Rushworth SA. NADPH oxidase-2 derived superoxide drives mitochondrial transfer from bone marrow stromal cells to leukemic blasts. Blood. 2017;130(14):1649\u201360.","journal-title":"Blood"},{"issue":"12","key":"2056_CR6","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.trecan.2017.10.003","volume":"3","author":"E Griessinger","year":"2017","unstructured":"Griessinger E, Moschoi R, Biondani G, Peyron JF. Mitochondrial transfer in the leukemia microenvironment. Trends Cancer. 2017;3(12):828\u201339.","journal-title":"Trends Cancer"},{"issue":"20","key":"2056_CR7","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.1182\/bloodadvances.2020003661","volume":"5","author":"K Saito","year":"2021","unstructured":"Saito K, Zhang Q, Yang H, Yamatani K, Ai T, Ruvolo V, Baran N, Cai T, Ma H, Jacamo R, et al. Exogenous mitochondrial transfer and endogenous mitochondrial fission facilitate AML resistance to OxPhos inhibition. Blood Adv. 2021;5(20):4233\u201355.","journal-title":"Blood Adv"},{"issue":"1","key":"2056_CR8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41568-021-00407-4","volume":"22","author":"ST Diepstraten","year":"2022","unstructured":"Diepstraten ST, Anderson MA, Czabotar PE, Lessene G, Strasser A, Kelly GL. The manipulation of apoptosis for cancer therapy using BH3-mimetic drugs. Nat Rev Cancer. 2022;22(1):45\u201364.","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"2056_CR9","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/s41419-020-03144-y","volume":"11","author":"I Kapoor","year":"2020","unstructured":"Kapoor I, Bodo J, Hill BT, Hsi ED, Almasan A. Targeting BCL-2 in B-cell malignancies and overcoming therapeutic resistance. Cell Death Dis. 2020;11(11):941.","journal-title":"Cell Death Dis"},{"issue":"13","key":"2056_CR10","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1182\/blood.2020006785","volume":"138","author":"AW Roberts","year":"2021","unstructured":"Roberts AW, Wei AH, Huang DCS. BCL2 and MCL1 inhibitors for hematologic malignancies. Blood. 2021;138(13):1120\u201336.","journal-title":"Blood"},{"issue":"9","key":"2056_CR11","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1182\/blood.2019003124","volume":"136","author":"MT Gebru","year":"2020","unstructured":"Gebru MT, Atkinson JM, Young MM, Zhang L, Tang Z, Liu Z, Lu P, Dower CM, Chen L, Annageldiyev C, et al. Glucocorticoids enhance the antileukemic activity of FLT3 inhibitors in FLT3-mutant acute myeloid leukemia. Blood. 2020;136(9):1067\u201379.","journal-title":"Blood"},{"issue":"6","key":"2056_CR12","doi-asserted-by":"crossref","first-page":"988","DOI":"10.3324\/haematol.2017.184267","volume":"103","author":"S Bertoli","year":"2018","unstructured":"Bertoli S, Picard M, Berard E, Griessinger E, Larrue C, Mouchel PL, Vergez F, Tavitian S, Yon E, Ruiz J, et al. Dexamethasone in hyperleukocytic acute myeloid leukemia. Haematologica. 2018;103(6):988\u201398.","journal-title":"Haematologica"},{"issue":"4","key":"2056_CR13","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ajh.26083","volume":"96","author":"JL Kaufman","year":"2021","unstructured":"Kaufman JL, Gasparetto C, Schjesvold FH, Moreau P, Touzeau C, Facon T, Boise LH, Jiang Y, Yang X, Dunbar F, et al. Targeting BCL-2 with venetoclax and dexamethasone in patients with relapsed\/refractory t(11;14) multiple myeloma. Am J Hematol. 2021;96(4):418\u201327.","journal-title":"Am J Hematol"},{"issue":"18","key":"2056_CR14","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1182\/blood-2013-08-519470","volume":"123","author":"RW Rooswinkel","year":"2014","unstructured":"Rooswinkel RW, van de Kooij B, de Vries E, Paauwe M, Braster R, Verheij M, Borst J. Antiapoptotic potency of Bcl-2 proteins primarily relies on their stability, not binding selectivity. Blood. 2014;123(18):2806\u201315.","journal-title":"Blood"},{"issue":"1","key":"2056_CR15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13045-018-0554-z","volume":"11","author":"J Wang","year":"2018","unstructured":"Wang J, Liu X, Qiu Y, Shi Y, Cai J, Wang B, Wei X, Ke Q, Sui X, Wang Y, et al. Cell adhesion-mediated mitochondria transfer contributes to mesenchymal stem cell-induced chemoresistance on T cell acute lymphoblastic leukemia cells. J Hematol Oncol. 2018;11(1):11.","journal-title":"J Hematol Oncol"},{"issue":"3","key":"2056_CR16","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3390\/cancers14030659","volume":"14","author":"A Allegra","year":"2022","unstructured":"Allegra A, Di Gioacchino M, Cancemi G, Casciaro M, Petrarca C, Musolino C, Gangemi S. Specialized intercellular communications via tunnelling nanotubes in acute and chronic leukemia. Cancers (Basel). 2022;14(3):659.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"2056_CR17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41392-020-00440-z","volume":"6","author":"D Liu","year":"2021","unstructured":"Liu D, Gao Y, Liu J, Huang Y, Yin J, Feng Y, Shi L, Meloni BP, Zhang C, Zheng M, et al. Intercellular mitochondrial transfer as a means of tissue revitalization. Signal Transduct Target Ther. 2021;6(1):65.","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"2056_CR18","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1158\/2159-8290.CD-13-0609","volume":"4","author":"R Pan","year":"2014","unstructured":"Pan R, Hogdal LJ, Benito JM, Bucci D, Han L, Borthakur G, Cortes J, DeAngelo DJ, Debose L, Mu H, et al. Selective BCL-2 inhibition by ABT-199 causes on-target cell death in acute myeloid leukemia. Cancer Discov. 2014;4(3):362\u201375.","journal-title":"Cancer Discov"},{"issue":"1","key":"2056_CR19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40164-022-00283-0","volume":"11","author":"Y Xu","year":"2022","unstructured":"Xu Y, Ye H. Progress in understanding the mechanisms of resistance to BCL-2 inhibitors. Exp Hematol Oncol. 2022;11(1):31.","journal-title":"Exp Hematol Oncol"},{"issue":"4","key":"2056_CR20","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ccell.2019.09.008","volume":"36","author":"R Thijssen","year":"2019","unstructured":"Thijssen R, Roberts AW. Venetoclax in Lymphoid Malignancies: new insights. More to Learn Cancer Cell. 2019;36(4):341\u20133.","journal-title":"More to Learn Cancer Cell"},{"issue":"3","key":"2056_CR21","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1158\/2159-8290.CD-18-1119","volume":"9","author":"P Blombery","year":"2019","unstructured":"Blombery P, Anderson MA, Gong JN, Thijssen R, Birkinshaw RW, Thompson ER, Teh CE, Nguyen T, Xu Z, Flensburg C, et al. Acquisition of the recurrent Gly101Val mutation in BCL2 confers resistance to Venetoclax in patients with progressive chronic lymphocytic leukemia. Cancer Discov. 2019;9(3):342\u201353.","journal-title":"Cancer Discov"},{"issue":"9","key":"2056_CR22","doi-asserted-by":"crossref","first-page":"e434","DOI":"10.3324\/haematol.2019.222588","volume":"104","author":"E Tausch","year":"2019","unstructured":"Tausch E, Close W, Dolnik A, Bloehdorn J, Chyla B, Bullinger L, Dohner H, Mertens D, Stilgenbauer S. Venetoclax resistance and acquired BCL2 mutations in chronic lymphocytic leukemia. Haematologica. 2019;104(9):e434-7.","journal-title":"Haematologica"},{"issue":"8","key":"2056_CR23","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1182\/blood.2021013788","volume":"139","author":"F Izzo","year":"2022","unstructured":"Izzo F, Landau DA. A BAX door to venetoclax resistance. Blood. 2022;139(8):1124\u20136.","journal-title":"Blood"},{"key":"2056_CR24","doi-asserted-by":"crossref","first-page":"1005659","DOI":"10.3389\/fonc.2022.1005659","volume":"12","author":"J Liu","year":"2022","unstructured":"Liu J, Chen Y, Yu L, Yang L. Mechanisms of venetoclax resistance and solutions. Front Oncol. 2022;12:1005659.","journal-title":"Front Oncol"},{"issue":"1","key":"2056_CR25","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1186\/s12885-017-3383-5","volume":"17","author":"SK Tahir","year":"2017","unstructured":"Tahir SK, Smith ML, Hessler P, Rapp LR, Idler KB, Park CH, Leverson JD, Lam LT. Potential mechanisms of resistance to venetoclax and strategies to circumvent it. BMC Cancer. 2017;17(1):399.","journal-title":"BMC Cancer"},{"issue":"6","key":"2056_CR26","first-page":"1681","volume":"8","author":"S Greenstein","year":"2002","unstructured":"Greenstein S, Ghias K, Krett NL, Rosen ST. Mechanisms of glucocorticoid-mediated apoptosis in hematological malignancies. Clinical cancer research. 2002;8(6):1681\u201394.","journal-title":"Clinical cancer research"},{"issue":"11","key":"2056_CR27","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S1470-2045(10)70114-5","volume":"11","author":"H Inaba","year":"2010","unstructured":"Inaba H, Pui CH. Glucocorticoid use in acute lymphoblastic leukaemia. Lancet Oncol. 2010;11(11):1096\u2013106.","journal-title":"Lancet Oncol"},{"issue":"1","key":"2056_CR28","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0145-2126(96)00089-6","volume":"21","author":"H Miyoshi","year":"1997","unstructured":"Miyoshi H, Ohki M, Nakagawa T, Honma Y. Glucocorticoids induce apoptosis in acute myeloid leukemia cell lines with A t(8;21) chromosome translocation. Leuk Res. 1997;21(1):45\u201350.","journal-title":"Leuk Res"},{"issue":"22","key":"2056_CR29","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1158\/1078-0432.CCR-17-1259","volume":"23","author":"L Simon","year":"2017","unstructured":"Simon L, Lavallee VP, Bordeleau ME, Krosl J, Baccelli I, Boucher G, Lehnertz B, Chagraoui J, MacRae T, Ruel R, et al. Chemogenomic landscape of RUNX1-mutated AML reveals importance of RUNX1 allele dosage in genetics and glucocorticoid sensitivity. Clinical cancer research. 2017;23(22):6969\u201381.","journal-title":"Clinical cancer research"},{"key":"2056_CR30","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3389\/fmed.2017.00211","volume":"4","author":"V Andresen","year":"2017","unstructured":"Andresen V, Gjertsen BT. Drug repurposing for the treatment of acute Myeloid Leukemia. Front Med. 2017;4:211.","journal-title":"Front Med"},{"issue":"8","key":"2056_CR31","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/pbc.26011","volume":"63","author":"K Klein","year":"2016","unstructured":"Klein K, Haarman EG, de Haas V, Zwaan ChM, Creutzig U, Kaspers GL. Glucocorticoid-induced proliferation in untreated pediatric acute myeloid leukemic blasts. Pediatr Blood Cancer. 2016;63(8):1457\u201360.","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"2056_CR32","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.leukres.2005.05.015","volume":"30","author":"G Hicsonmez","year":"2006","unstructured":"Hicsonmez G. The effect of steroid on myeloid leukemic cells: the potential of short-course high-dose methylprednisolone treatment in inducing differentiation, apoptosis and in stimulating myelopoiesis. Leuk Res. 2006;30(1):60\u20138.","journal-title":"Leuk Res"},{"issue":"4","key":"2056_CR33","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/(SICI)1096-8652(199904)60:4<255::AID-AJH1>3.0.CO;2-S","volume":"60","author":"N Ozbek","year":"1999","unstructured":"Ozbek N, Erdemli E, Hicsonmez G, Okur H, Tekelioglu M. Effects of methylprednisolone on human myeloid leukemic cells in vitro. Am J Hematol. 1999;60(4):255\u20139.","journal-title":"Am J Hematol"},{"issue":"12","key":"2056_CR34","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41408-017-0011-1","volume":"7","author":"S Bertoli","year":"2017","unstructured":"Bertoli S, Tavitian S, Huynh A, Borel C, Guenounou S, Luquet I, Delabesse E, Sarry A, Laurent G, Attal M, et al. Improved outcome for AML patients over the years 2000\u20132014. Blood Cancer J. 2017;7(12):635.","journal-title":"Blood Cancer J"},{"issue":"4","key":"2056_CR35","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1600-0609.1992.tb01588.x","volume":"48","author":"G Hicsonmez","year":"1992","unstructured":"Hicsonmez G, Karadeniz N, Zamani VP, Tuncer AM, Gumruk F, Erturk G, Gurgey A, Ozsoylu S. High remission rate in acute myeloblastic leukemia in children treated with high-dose methylprednisolone. Eur J Haematol. 1992;48(4):215\u201320.","journal-title":"Eur J Haematol"},{"key":"2056_CR36","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V128.22.1636.1636","author":"C Recher","year":"2016","unstructured":"Recher C, Bertoli S, Picard M, Berard E, Larrue C, Tavitian S, Vergez F, Yon E, Ruiz J, Delabesse E, et al. Dexamethasone reduces incidence of relapse and improves overall survival in hyperleucocytic acute myeloid leukemia. Blood. 2016. https:\/\/doi.org\/10.1182\/blood.V128.22.1636.1636.","journal-title":"Blood"},{"key":"2056_CR37","doi-asserted-by":"crossref","first-page":"36199","DOI":"10.1038\/srep36199","volume":"6","author":"M Kurata","year":"2016","unstructured":"Kurata M, Rathe SK, Bailey NJ, Aumann NK, Jones JM, Veldhuijzen GW, Moriarity BS, Largaespada DA. Using genome-wide CRISPR library screening with library resistant DCK to find new sources of Ara-C drug resistance in AML. Sci Rep. 2016;6:36199.","journal-title":"Sci Rep"},{"issue":"5","key":"2056_CR38","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/leu.2016.314","volume":"31","author":"D Malani","year":"2017","unstructured":"Malani D, Murumagi A, Yadav B, Kontro M, Eldfors S, Kumar A, Karjalainen R, Majumder MM, Ojamies P, Pemovska T, et al. Enhanced sensitivity to glucocorticoids in cytarabine-resistant AML. Leukemia. 2017;31(5):1187\u201395.","journal-title":"Leukemia"},{"issue":"3\u20134","key":"2056_CR39","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3109\/10428199609051608","volume":"20","author":"LA Smets","year":"1996","unstructured":"Smets LA, van den Berg JD. Bcl-2 expression and glucocorticoid-induced apoptosis of leukemic and lymphoma cells. Leuk Lymphoma. 1996;20(3\u20134):199\u2013205.","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"2056_CR40","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00204-014-1448-7","volume":"89","author":"WA Siddiqui","year":"2015","unstructured":"Siddiqui WA, Ahad A, Ahsan H. The mystery of BCL2 family: Bcl-2 proteins and apoptosis: an update. Arch Toxicol. 2015;89(3):289\u2013317.","journal-title":"Arch Toxicol"},{"issue":"3","key":"2056_CR41","first-page":"321","volume":"5","author":"J Lotem","year":"1994","unstructured":"Lotem J, Sachs L. Control of sensitivity to induction of apoptosis in myeloid leukemic cells by differentiation and bcl-2 dependent and independent pathways. Cell Growth Differ. 1994;5(3):321\u20137.","journal-title":"Cell Growth Differ"},{"issue":"1","key":"2056_CR42","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagrm.2019.194475","volume":"1863","author":"L Rocha-Viegas","year":"2020","unstructured":"Rocha-Viegas L, Silbermins M, Ogara MF, Pellegrini JM, Nunez SY, Garcia VE, Vicent GP, Pecci A. Glucocorticoids uncover a critical role for ASH2L on BCL-X expression regulation in leukemia cells. Biochim Biophys Acta Gene Regul Mech. 2020;1863(1): 194475.","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"issue":"2","key":"2056_CR43","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10495-006-0624-5","volume":"12","author":"I Herr","year":"2007","unstructured":"Herr I, Gassler N, Friess H, Buchler MW. Regulation of differential pro- and anti-apoptotic signaling by glucocorticoids. Apoptosis. 2007;12(2):271\u201391.","journal-title":"Apoptosis"},{"key":"2056_CR44","doi-asserted-by":"crossref","first-page":"27696","DOI":"10.1038\/srep27696","volume":"6","author":"KH Lin","year":"2016","unstructured":"Lin KH, Winter PS, Xie A, Roth C, Martz CA, Stein EM, Anderson GR, Tingley JP, Wood KC. Targeting MCL-1\/BCL-XL forestalls the acquisition of resistance to ABT-199 in acute Myeloid Leukemia. Sci Rep. 2016;6:27696.","journal-title":"Sci Rep"},{"issue":"4","key":"2056_CR45","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/bjh.17940","volume":"196","author":"HMM Ahmed","year":"2022","unstructured":"Ahmed HMM, Nimmagadda SC, Al-Matary YS, Fiori M, May T, Frank D, Patnana PK, Recher C, Schliemann C, Mikesch JH, et al. Dexamethasone-mediated inhibition of Notch signalling blocks the interaction of leukaemia and mesenchymal stromal cells. Br J Haematol. 2022;196(4):995\u20131006.","journal-title":"Br J Haematol"},{"issue":"5","key":"2056_CR46","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.cmet.2020.09.001","volume":"32","author":"D Forte","year":"2020","unstructured":"Forte D, Garcia-Fernandez M, Sanchez-Aguilera A, Stavropoulou V, Fielding C, Martin-Perez D, Lopez JA, Costa ASH, Tronci L, Nikitopoulou E, et al. Bone marrow mesenchymal stem cells support acute myeloid leukemia bioenergetics and enhance antioxidant defense and escape from chemotherapy. Cell Metab. 2020;32(5):829\u201343.","journal-title":"Cell Metab"},{"issue":"17","key":"2056_CR47","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1182\/blood.2019001398","volume":"134","author":"R Burt","year":"2019","unstructured":"Burt R, Dey A, Aref S, Aguiar M, Akarca A, Bailey K, Day W, Hooper S, Kirkwood A, Kirschner K, et al. Activated stromal cells transfer mitochondria to rescue acute lymphoblastic leukemia cells from oxidative stress. Blood. 2019;134(17):1415\u201329.","journal-title":"Blood"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-023-02056-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-023-02056-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-023-02056-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T17:17:44Z","timestamp":1687886264000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-023-02056-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,1]]},"references-count":47,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["2056"],"URL":"https:\/\/doi.org\/10.1007\/s12032-023-02056-z","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,1]]},"assertion":[{"value":"2 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All studies performed with human specimens were done with approval from the First Hospital of Anhui Medical University. Ethical approval and informed consent were obtained for the use of human samples. Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"193"}}